Binding of TRAIL to decoy receptors on cancer cells impedes apoptotic signals, while its binding to active receptors induces caspase-mediated apoptosis, leading to programmed cell death [35], with no off-target cytotoxicity. Here, TNFSF10 is linked to cancer.